Logo
  • Home
  • About Us
  • Services
    • Patents
      • Patent Searching
      • Patent Drafting
      • Patent Filing
      • Patent Prosecution
      • Patent Opposition
    • Trademarks
    • Copyrights
    • Designs
  • Blog & News
  • Career
  • Contact Us

New Drug Approved_May 2016

  1. Home
  2. IPaatEntiti
  3. New Drug Approved_May 2016
June 7, 2016 | ipaatentiti | IPaatEntiti

New Drug Approved_May 2016

Original New Drug Application (NDA and BLA) New molecular entity_ Approvals-May 2016

Active Ingredient(s); Drug nameCompanyApproval Date
FLUCICLOVINE; AXUMIN (NDA)BLUE EARTH DIAGNOSTICS LTD27/05/2016
DACLIZUMAB; ZINBRYTA (BLA)BIOGEN27/05/2016

About the Author

ipaatentiti

Post navigation

New Indian IPR Policy_India
Subject Matter Eligibility of Software related Patents

Recent Posts

  • GREAT NEWS FOR ALL INDIAN EDUCATIONAL INSTITUTES TO BOOST THEIR INNOVATION
  • Decathlon Sues Pentathlon for Trademark Infringement
  • Government Proposal to Shut Down IPAB
  • DRAFT PATENTS (AMENDMENT) RULES, 2021
  • New Beginnings
  • Delhi HC ruled in favour of “MakeMyTrip”- Temporary ad-interim injunction continues
  • DPIIT Launches Website and Mobile App for IPR
  • The Patents (Amendment) Rules, 2019
  • New IPR Policy for Academic Institutions on the anvil
  • Government of India initiative to boost Intellectual Property Rights
  • Burden of Proof in case of Process Patent
  • Hindustan Zinc receives its first European patent
  • Patent infringement actions are maintainable only in respect of granted and live patents
  • Patentability of Microorganisms in India
  • Expedited Examination Procedure in Indian Patent System
  • Sample Page

Copyright ©2025 IPaatEntiti | Blog . All rights reserved. Designed by InvoAds